Prescription medicines registrations
Search registrations for new medicines including generic medicines, chemical and biological entities (NCE and NBE), biosimilar medicines, biologicals and combinations. You can also search extensions of indications, which describes new uses of medicines.
More information on prescription medicine registration:
- For registration types visit Prescription medicines and biologicals: new registrations.
- For NCE registrations before 2018 visit Prescription medicines: registration of new chemical entities in Australia.
- For EOI registrations before 2018 visit Prescription medicines: new or extended uses, or new combinations of registered medicines.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Search
65 result(s) found, displaying 1 to 25
-
-
Prescription medicine registrationActive ingredients: empagliflozin.
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: migalastat hydrochloride.
-
-
-
Prescription medicine registrationActive ingredients: elexacaftor, ivacaftor, tezacaftor.
-
Prescription medicine registrationActive ingredients: brolucizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: Belimumab.
-
Prescription medicine registrationActive ingredients: tozinameran.
-
-
Prescription medicine registrationActive ingredients: upadacitinib hemihydrate.
-
Prescription medicine registrationActive ingredients: Secukinumab.
-
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: ravulizumab.
-
Prescription medicine registrationActive ingredients: cabotegravir sodium, cabotegravir.
-
Prescription medicine registrationActive ingredients: SARS-CoV-2 rS (NVX-CoV2373).
-
Prescription medicine registrationActive ingredients: elasomeran.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
Prescription medicine registrationActive ingredients: trastuzumab deruxtecan.
-
Prescription medicine registrationActive ingredients: thiotepa.